David R. McAvoy - 14 Jun 2021 Form 4 Insider Report for Brickell Biotech, Inc.

Role: General Counsel and CCO
Signature: /s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed)
Issuer symbol: N/A
Transactions as of: 14 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2021, 16:43:57 UTC
Previous filing: 19 May 2021
Next filing: 27 Jul 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FRTX	Stock Option (right to buy)	Award	$0	+200,000		$0.000000	200,000	14 Jun 2021	Common Stock	200,000	$0.9000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options will vest 25% on June 14, 2022, and the remainder will vest in equal monthly installments over the following three years.